PCM
PETX

Piermont Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Piermont Capital Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-56,734
Closed -$407K – 287
2016
Q4 		$407K Sell
56,734
-1,100
-2% -$7.89K 0.09% 242
2016
Q3 		$541K Buy
+57,834
New +$541K 0.13% 229